Trial Profile
A Multicenter Randomized, Double-blind, Placebo-controlled Study of MP-435 in Combination With MTX in Patients With Rheumatoid Arthritis - Exploratory Study.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Apr 2023
Price :
$35
*
At a glance
- Drugs MP 435 (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Mitsubishi Tanabe Pharma Corporation
- 21 Mar 2012 Actual patient number 112 added as reported by ClinicalTrials.gov.
- 21 Mar 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 21 Dec 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.